Abstract
Classical neurologic teaching suggests that a higher cerebral systemic blood pressure (BP) be targeted for individuals with occlusive carotid disease, in order to improve cerebral perfusion through collaterals. This conflicts, however, with observational population-based studies and clinical trials supporting better outcomes associated with lower BPs. In this issue of Neurology®, Powers et al.1 evaluate nonsurgical controls from the Carotid Occlusion Surgery Study (COSS) and report lower rates of stroke recurrence in individuals maintained at a follow-up BP of 130/85 mm Hg or lower
Original language | English |
---|---|
Pages (from-to) | 1018-1019 |
Number of pages | 3 |
Journal | Neurology |
Volume | 82 |
Issue number | 12 |
DOIs | |
Publication status | Published - 25 Mar 2014 |
Externally published | Yes |
Keywords
- blood pressure
- occlusive carotid disease